Free Newsletter Subscription
        MCN All Access

Report: Allen Has Non-Hodgkin's Lymphoma

Charter Chairman Undergoing Chemo

Mike Farrell -- Multichannel News, 11/17/2009 11:11:00 PM

A report in The Wall Street Journal Tuesday said that Charter Communications chairman and Microsoft co-founder Paul was diagnosed with non-Hodgkin's lymphoma earlier this month and is undergoing chemotherapy treatments.
Vulcan Inc., Allen's Seattle private investment arm, confirmed The Journal report and that Allen was undergoing treatment.
In an e-mail sent to employees Monday, Vulcan CEO Jody Allen (Paul Allen's sister) said her brother was "feeling OK and remains upbeat," and continues to work.
"This is tough news for Paul and the family," Jody Allen continued. "But for those who know Paul's story, you know he beat Hodgkin's a little more than 25 years ago and he is optimistic he can beat this, too."
Allen left Microsoft in 1983 after being diagnosed with Hodgkin's disease and recovered.
Related Content

No related content found.

More >>>

Newbay Business Information Resource Center

Featured Company


Most Recent Resources

Advertisement
More Content
  • Voices
  • Photos
  • Podcasts

Jon Lafayette

Counter Programming

Jon Lafayette
February 15, 2010
Difficult Tales Told By Reporter on HBO
The film Reporter documents several tragedies at once. The first is a story of...
More

Scott Greczkowski

The Satellite Dish

Scott Greczkowski
February 15, 2010
RFD-TV Gets a Stay
As we reported in Fridays edition of “The Satellite Dish” it looked...
More

Satellite Entourage

FREEZE FRAME

Parties, conferences and events for the week of Feb. 8.
DESIGN BY NIGHT

FREEZE FRAME

Parties, conferences and events for the week of Feb. 1.
KEYSTONE HUNT

FREEZE FRAME

Parties, conferences and events for the week of Dec. 14.



Advertisement
About Us   |   Advertising Info   |   Site Map   |   Contact Us   |   Subscription   |   Affiliate Links   |   RSS
© 2011 NewBay Media, LLC. 28 East 28th Street, 12th floor, New York, NY 10016 T (212) 378-0400 F (212) 378-0470
Use of this website is subject to its Terms of Use | Privacy Policy